MCC950 is a potent and specific inhibitor of the NLRP3 inflammasome and a novel potential therapeutic for NLRP3 driven diseases

Rebecca C Coll, Avril AB Robertson, Jae Jin Chae, Sarah C Higgins, Lara S Dungan, Raul Munoz-Planillo, Brian G Monks, Daniel E Croker, Caroline E Sutton, Andrea Stutz, Gabriel Nunez, Eicke Latz, Daniel L Kastner, Kingston HG Mills, Seth L Masters, Kate Schroder, Matt A Cooper, Luke AJ O'Neill